Nooresh Mirani of AMSEC Research recommends buying CESC with a target price of Rs 450 in the long-term and advises to buy Aurobindo Pharma with a target price of Rs 200 and a stop loss at Rs 187.
first published: Jul 9, 2013 01:52 pm
A collection of the most-viewed Moneycontrol videos.

Live: Nifty recovers 100 pts from day's low, metals under pressure | Closing Bell

Govt to stick to the path of fiscal consolidation - Prof Dev, PMEC chairman

Budget 2026 expectations: Taxpayers eye higher standard deduction, home loan interest relief

Live: Will Nifty take a breather after 3-day rally amid mixed global cues | Opening Bell
You are already a Moneycontrol Pro user.